000 01726 a2200469 4500
005 20250514035357.0
264 0 _c20030221
008 200302s 0 0 eng d
022 _a1043-4666
024 7 _a10.1006/cyto.2002.1024
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPozo, David
245 0 0 _aVasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit LPS-stimulated MIP-1alpha production and mRNA expression.
_h[electronic resource]
260 _bCytokine
_cApr 2002
300 _a35-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Line
650 0 4 _aCells, Cultured
650 0 4 _aChemokine CCL3
650 0 4 _aChemokine CCL4
650 0 4 _aChemokines
_xmetabolism
650 0 4 _aCyclic AMP
_xmetabolism
650 0 4 _aCyclic AMP-Dependent Protein Kinases
_xmetabolism
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDown-Regulation
650 0 4 _aLipopolysaccharides
_xmetabolism
650 0 4 _aMacrophage Inflammatory Proteins
_xmetabolism
650 0 4 _aMice
650 0 4 _aNeuropeptides
_xmetabolism
650 0 4 _aPituitary Adenylate Cyclase-Activating Polypeptide
650 0 4 _aProtein Kinase C
_xmetabolism
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSignal Transduction
650 0 4 _aTime Factors
650 0 4 _aVasoactive Intestinal Peptide
_xmetabolism
700 1 _aGuerrero, Juan M
700 1 _aCalvo, Juan R
773 0 _tCytokine
_gvol. 18
_gno. 1
_gp. 35-42
856 4 0 _uhttps://doi.org/10.1006/cyto.2002.1024
_zAvailable from publisher's website
999 _c11984996
_d11984996